PLG and neoplasm: In particular, bikunin represses cell-bound plasmin activity [32,33] and is thought to inhibit CD44 dimerization and suppress the MAP kinase signalling cascade[58], thus preventing ECM degradation, tumor cell invasion, and angiogenesis.